Target Name: LRRC74A
NCBI ID: G145497
Review Report on LRRC74A Target / Biomarker Content of Review Report on LRRC74A Target / Biomarker
LRRC74A
Other Name(s): LRRC74A variant 1 | leucine rich repeat containing 74A | Leucine rich repeat containing 74A, transcript variant 1 | LR74A_HUMAN | Leucine-rich repeat-containing protein 74 | leucine-rich repeat-containing protein 74 | LRRC74 | Uncharacterized protein C14orf166B | Leucine-rich repeat-containing protein 74A | Leucine-rich repeat-containing protein 74A (isoform 1) | leucine rich repeat containing 74 | C14orf166B

LRRC74A: A Non-Coding RNA Molecule as A Potential Drug Target Or Biomarker

LRRC74A, also known as LRRC74A variant 1, is a non-coding RNA molecule that has been identified as a potential drug target or biomarker. Its unique structure and function have made it an attractive target for researchers to study.

The LRRC74A molecule is approximately 200 amino acids long and has a unique five-arm structure. It is composed of a central alpha helix and four beta-helices that give it a repeating pattern of the amino acids alanine, glutamic acid, aspartic acid, and glycine. The LRRC74A molecule has a pre-伪 structure that consists of a long alpha-helices and a short alpha-helix, which is similar to that of the LDL receptor.

The LRRC74A molecule has been shown to play a role in the regulation of various cellular processes, including cell adhesion, migration, and the association with signaling pathways. One of the most significant functions of LRRC74A is its role in cell adhesion. to be involved in the regulation of tight junction formation and the maintenance of cell-cell adhesion.

In addition to its role in cell adhesion, LRRC74A has also been shown to play a role in the regulation of cell migration. LRRC74A has been shown to be involved in the regulation of cell migration, and it has been shown to play a negative role in the migration of cancer cells.

LRRC74A has also been shown to be involved in the regulation of various signaling pathways. For example, LRRC74A has been shown to play a role in the regulation of the TGF-β pathway. TGF-β is a well-known signaling pathway that is involved in the regulation of cell growth, differentiation, and inflammation. LRRC74A has been shown to be involved in the regulation of TGF-β activity, and it has been shown to play a positive role in the regulation of cell proliferation.

LRRC74A has also been shown to have potential as a biomarker. Its unique structure and function make it an attractive target for researchers to study. By studying the regulation of LRRC74A, researchers may be able to gain insights into the mechanisms of cell adhesion, migration, and signaling pathways. This, in turn, may lead to the development of new drugs or therapies for various diseases.

In conclusion, LRRC74A is a non-coding RNA molecule that has been shown to play a role in the regulation of various cellular processes, including cell adhesion, migration, and the association with signaling pathways. Its unique structure and function make it an attractive target for researchers to study, and its potential as a biomarker makes it a valuable tool for the development of new drugs or therapies. Further research is needed to fully understand the mechanisms of LRRC74A and its role in cellular processes.

Protein Name: Leucine Rich Repeat Containing 74A

The "LRRC74A Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LRRC74A comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LRRC74B | LRRC75A | LRRC75B | LRRC8A | LRRC8B | LRRC8C | LRRC8C-DT | LRRC8D | LRRC8E | LRRC9 | LRRCC1 | LRRD1 | LRRFIP1 | LRRFIP1P1 | LRRFIP2 | LRRIQ1 | LRRIQ3 | LRRIQ4 | LRRK1 | LRRK2 | LRRN1 | LRRN2 | LRRN3 | LRRN4 | LRRN4CL | LRRTM1 | LRRTM2 | LRRTM3 | LRRTM4 | LRSAM1 | LRTM1 | LRTM2 | LRTOMT | LRWD1 | LSAMP | LSG1 | LSINCT5 | LSm Protein Complex | LSM1 | Lsm1-7 complex | LSM10 | LSM11 | LSM12 | LSM14A | LSM14B | LSM2 | LSM3 | LSM4 | LSM5 | LSM6 | LSM7 | LSM8 | LSMEM1 | LSMEM2 | LSP1 | LSP1P2 | LSP1P3 | LSP1P4 | LSP1P5 | LSR | LSS | LST1 | LTA | LTA4H | LTB | LTB4R | LTB4R2 | LTBP1 | LTBP2 | LTBP3 | LTBP4 | LTBR | LTC4S | LTF | LTK | LTN1 | LTO1 | LTV1 | LUADT1 | LUC7L | LUC7L2 | LUC7L3 | LUCAT1 | LUM | LUNAR1 | LURAP1 | LURAP1L | LURAP1L-AS1 | Luteinizing hormone | LUZP1 | LUZP2 | LUZP4 | LUZP6 | LVRN | LXN | LY6D | LY6E | LY6E-DT | LY6G5B | LY6G5C